AAAAAA
Results:
1-13
|
Results: 13
Authors:
Lukas, RJ
Lucero, L
Buisson, B
Galzi, JL
Puchacz, E
Fryer, JD
Changeux, JP
Bertrand, D
Citation: Rj. Lukas et al., Neurotoxicity of channel mutations in heterologously expressed alpha 7-nicotinic acetylcholine receptors, EUR J NEURO, 13(10), 2001, pp. 1849-1860
Authors:
Pacheco, MA
Pastoor, TE
Lukas, RJ
Wecker, L
Citation: Ma. Pacheco et al., Characterization of human alpha 4 beta 2 neuronal nicotinic receptors stably expressed in SH-EP1 cells, NEUROCHEM R, 26(6), 2001, pp. 683-693
Authors:
Ferchmin, PA
Lukas, RJ
Hann, RM
Fryer, JD
Eaton, JB
Pagan, OR
Rodriguez, AD
Nicolau, Y
Rosado, M
Cortes, S
Eterovic, VA
Citation: Pa. Ferchmin et al., Tobacco cembranoids block behavioral sensitization to nicotine and inhibitneuronal acetylcholine receptor function, J NEUROSC R, 64(1), 2001, pp. 18-25
Authors:
Gentry, CL
Lukas, RJ
Citation: Cl. Gentry et Rj. Lukas, Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes, J PHARM EXP, 299(3), 2001, pp. 1038-1048
Authors:
Houlihan, LM
Slater, Y
Guerra, DL
Peng, JH
Kuo, YP
Lukas, RJ
Cassels, BK
Bermudez, I
Citation: Lm. Houlihan et al., Activity of cytisine and its brominated isosteres on recombinant human alpha 7, alpha 4 beta 2 and alpha 4 beta 4 nicotinic acetylcholine receptors, J NEUROCHEM, 78(5), 2001, pp. 1029-1043
Authors:
Houlihan, LM
Slater, EY
Beadle, DJ
Lukas, RJ
Bermudez, I
Citation: Lm. Houlihan et al., Effects of diltiazem on human nicotinic acetylcholine and GABA(A) receptors, NEUROPHARM, 39(13), 2000, pp. 2533-2542
Authors:
Blanton, MP
McCardy, EA
Fryer, JD
Liu, MH
Lukas, RJ
Citation: Mp. Blanton et al., 5-Hydroxytryptamine interaction with the nicotinic acetylcholine receptor, EUR J PHARM, 389(2-3), 2000, pp. 155-163
Authors:
Lukas, RJ
Changeux, JP
Le Novere, N
Albuquerque, EX
Balfour, DJK
Berg, DK
Bertrand, D
Chiappinelli, VA
Clarke, PBS
Collins, AC
Dani, JA
Grady, SR
Kellar, KJ
Lindstrom, JM
Marks, MJ
Quik, M
Taylor, PW
Wonnacott, S
Citation: Rj. Lukas et al., International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits, PHARM REV, 51(2), 1999, pp. 397-401
Authors:
Reitstetter, R
Lukas, RJ
Gruener, R
Citation: R. Reitstetter et al., Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure, J PHARM EXP, 289(2), 1999, pp. 656-660
Authors:
Fryer, JD
Lukas, RJ
Citation: Jd. Fryer et Rj. Lukas, Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine, J PHARM EXP, 288(1), 1999, pp. 88-92
Authors:
Fryer, JD
Lukas, RJ
Citation: Jd. Fryer et Rj. Lukas, Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function, J NEUROCHEM, 72(3), 1999, pp. 1117-1124
Authors:
Peng, JH
Lucero, L
Fryer, J
Herl, J
Leonard, SS
Lukas, RJ
Citation: Jh. Peng et al., Inducible, heterologous expression of human alpha 7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line, BRAIN RES, 825(1-2), 1999, pp. 172-179
Authors:
Sparks, DL
Beach, TG
Lukas, RJ
Citation: Dl. Sparks et al., Immunohistochemical localization of nicotinic beta 2 and alpha 4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations, NEUROSCI L, 256(3), 1998, pp. 151-154
Risultati:
1-13
|